{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T20:27:19Z","timestamp":1775680039299,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["DK106427"],"award-info":[{"award-number":["DK106427"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["HL123160"],"award-info":[{"award-number":["HL123160"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["DK104273"],"award-info":[{"award-number":["DK104273"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["DK100081"],"award-info":[{"award-number":["DK100081"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["DK76308"],"award-info":[{"award-number":["DK76308"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["tcmonline.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cardiovascular Medicine"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.tcm.2016.05.004","type":"journal-article","created":{"date-parts":[[2016,5,17]],"date-time":"2016-05-17T12:09:11Z","timestamp":1463486951000},"page":"700-706","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Emerging concepts for patients with treatment-resistant hypertension"],"prefix":"10.1016","volume":"26","author":[{"given":"Alfonso","family":"Eirin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen C.","family":"Textor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilach O.","family":"Lerman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tcm.2016.05.004_bib1","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/S0140-6736(12)61766-8","article-title":"A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lim","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.tcm.2016.05.004_bib2","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jash.2014.06.005","article-title":"Detection, evaluation, and treatment of severe and resistant hypertension: proceedings from an American Society of Hypertension Interactive forum held in Bethesda MD, U.S.A., October 10, 2013","volume":"8","author":"White","year":"2014","journal-title":"J Am Soc Hypertens"},{"key":"10.1016\/j.tcm.2016.05.004_bib3","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","article-title":"2013 ESH\/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"34","author":"Mancia","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2016.05.004_bib4","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1161\/HYPERTENSIONAHA.108.189141","article-title":"Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research","volume":"51","author":"Calhoun","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/j.tcm.2016.05.004_bib5","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1161\/HYPERTENSIONAHA.114.03850","article-title":"Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT)","volume":"64","author":"Muntner","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.tcm.2016.05.004_bib6","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/ki.2015.142","article-title":"Comparative risk of renal, cardiovascular, and mortality outcomes in controlled, uncontrolled resistant, and nonresistant hypertension","volume":"88","author":"Sim","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/j.tcm.2016.05.004_bib7","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1161\/01.HYP.0000016176.16042.2F","article-title":"Resistant hypertension: comparing hemodynamic management to specialist care","volume":"39","author":"Taler","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/j.tcm.2016.05.004_bib8","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1161\/HYPERTENSIONAHA.109.131235","article-title":"Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial","volume":"54","author":"Pimenta","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/j.tcm.2016.05.004_bib9","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1093\/ndt\/gfs384","article-title":"Resistant hypertension and the neglected antihypertensive: sodium restriction","volume":"27","author":"Agarwal","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.tcm.2016.05.004_bib10","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1161\/HYPERTENSIONAHA.115.05449","article-title":"Refractory hypertension: evidence of heightened sympathetic activity as a cause of antihypertensive treatment failure","volume":"66","author":"Dudenbostel","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.tcm.2016.05.004_bib11","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/HJH.0b013e32835e2286","article-title":"Resistant hypertension? Assessment of adherence by toxicological urine analysis","volume":"31","author":"Jung","year":"2013","journal-title":"J Hypertens"},{"key":"10.1016\/j.tcm.2016.05.004_bib12","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1097\/HJH.0b013e3283652c61","article-title":"Precise assessment of noncompliance with the antihypertensive therapy in patients with resistant hypertension using toxicological serum analysis","volume":"31","author":"Strauch","year":"2013","journal-title":"J Hypertens"},{"key":"10.1016\/j.tcm.2016.05.004_bib13","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1093\/eurheartj\/eht534","article-title":"Secondary arterial hypertension: when, who, and how to screen?","volume":"35","author":"Rimoldi","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.tcm.2016.05.004_bib14","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3109\/08037051.2013.812549","article-title":"2013 ESH\/ESC guidelines for the management of arterial hypertension","volume":"22","author":"Mancia","year":"2013","journal-title":"Blood Press"},{"key":"10.1016\/j.tcm.2016.05.004_bib15","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.2174\/13816128113199990315","article-title":"Hydrochlorothiazide vs. chlorthalidone as the optimal diuretic for the management of hypertension","volume":"19","author":"Tziomalos","year":"2013","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.tcm.2016.05.004_bib16","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/ndt\/gfh650","article-title":"A randomized trial of furosemide vs hydrochlorothiazide in patients with chronic renal failure and hypertension","volume":"20","author":"Dussol","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.tcm.2016.05.004_bib17","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1111\/nep.12475","article-title":"Management of resistant hypertension: aldosterone antagonists or intensification of diuretic therapy?","volume":"20","author":"Verdalles","year":"2015","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.tcm.2016.05.004_bib18","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/jhh.2014.64","article-title":"Effect of aldosterone antagonists on blood pressure in patients with resistant hypertension: a meta-analysis","volume":"29","author":"Liu","year":"2015","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.tcm.2016.05.004_bib19","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1161\/CIRCULATIONAHA.111.029892","article-title":"Effects of a novel aldosterone synthase inhibitor for treatment of primary hypertension: results of a randomized, double-blind, placebo- and active-controlled phase 2 trial","volume":"124","author":"Calhoun","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.tcm.2016.05.004_bib20","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1111\/jch.12051","article-title":"Study of aldosterone synthase inhibition as an add-on therapy in resistant hypertension","volume":"15","author":"Karns","year":"2013","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.tcm.2016.05.004_bib21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1751-7176.2011.00556.x","article-title":"Refractory hypertension: definition, prevalence, and patient characteristics","volume":"14","author":"Acelajado","year":"2012","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/j.tcm.2016.05.004_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/08037051.2014.946787","article-title":"Physician (investigator) inertia in apparent treatment-resistant hypertension - insights from large randomized clinical trials. Lennart Hansson Memorial Lecture","volume":"24","author":"Kjeldsen","year":"2015","journal-title":"Blood Press"},{"key":"10.1016\/j.tcm.2016.05.004_bib23","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/HYPERTENSIONAHA.115.06562","article-title":"J curve and cuff artefact, and diagnostic inertia in resistant hypertension","volume":"67","author":"Spence","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/j.tcm.2016.05.004_bib24","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.mayocp.2012.02.003","article-title":"Sustained blood pressure-lowering actions of subcutaneous B-type natriuretic peptide (nesiritide) in a patient with uncontrolled hypertension","volume":"87","author":"Cataliotti","year":"2012","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.tcm.2016.05.004_bib25","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1161\/HYPERTENSIONAHA.113.02002","article-title":"Efficacy and safety of LCZ696, a first-in-class angiotensin receptor neprilysin inhibitor, in Asian patients with hypertension: a randomized, double-blind, placebo-controlled study","volume":"63","author":"Kario","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.tcm.2016.05.004_bib26","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/hr.2014.160","article-title":"Higher circulatory level of endothelin-1 in hypertensive subjects screened through a cross-sectional study of rural Bangladeshi women","volume":"38","author":"Akter","year":"2015","journal-title":"Hypertens Res"},{"key":"10.1016\/j.tcm.2016.05.004_bib27","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S0140-6736(09)61500-2","article-title":"A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial","volume":"374","author":"Weber","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.tcm.2016.05.004_bib28","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1016\/j.clinthera.2013.10.012","article-title":"Etamicastat, a novel dopamine beta-hydroxylase inhibitor: tolerability, pharmacokinetics, and pharmacodynamics in patients with hypertension","volume":"35","author":"Almeida","year":"2013","journal-title":"Clin Ther"},{"key":"10.1016\/j.tcm.2016.05.004_bib29","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1748-1716.1958.tb01615.x","article-title":"Cardiovascular effects of direct stimulation of the carotid sinus nerve in man","volume":"44","author":"Carlsten","year":"1958","journal-title":"Acta Physiol Scand"},{"key":"10.1016\/j.tcm.2016.05.004_bib30","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/j.jacc.2010.03.089","article-title":"Novel baroreflex activation therapy in resistant hypertension: results of a European multi-center feasibility study","volume":"56","author":"Scheffers","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2016.05.004_bib31","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.jacc.2011.06.008","article-title":"Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial","volume":"58","author":"Bisognano","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.tcm.2016.05.004_bib32","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jash.2012.04.004","article-title":"Minimally invasive system for baroreflex activation therapy chronically lowers blood pressure with pacemaker-like safety profile: results from the Barostim neo trial","volume":"6","author":"Hoppe","year":"2012","journal-title":"J Am Soc Hypertens"},{"key":"10.1016\/j.tcm.2016.05.004_bib33","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S0140-6736(13)62192-3","article-title":"Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 Study","volume":"383","author":"Krum","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.tcm.2016.05.004_bib34","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(10)62039-9","article-title":"Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial","volume":"376","author":"Esler","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.tcm.2016.05.004_bib35","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1056\/NEJMoa1402670","article-title":"A controlled trial of renal denervation for resistant hypertension","volume":"370","author":"Bhatt","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tcm.2016.05.004_bib36","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1161\/HYPERTENSIONAHA.115.05283","article-title":"Randomized sham-controlled trial of renal sympathetic denervation in mild resistant hypertension","volume":"65","author":"Desch","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.tcm.2016.05.004_bib37","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1161\/HYPERTENSIONAHA.114.04019","article-title":"Randomized comparison of renal denervation versus intensified pharmacotherapy including spironolactone in true-resistant hypertension: six-month results from the Prague-15 Study","volume":"65","author":"Rosa","year":"2015","journal-title":"Hypertension"},{"issue":"Suppl. 1","key":"10.1016\/j.tcm.2016.05.004_bib38","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1097\/01.hjh.0000467641.39623.fb","article-title":"8b.05: failure of renal denervation in symplicity HTN-3 is a predictable result of anatomically inadequate operative technique and not the true limitations of the technology","volume":"33","author":"Pekarskiy","year":"2015","journal-title":"J Hypertens"},{"key":"10.1016\/j.tcm.2016.05.004_bib39","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/S0140-6736(14)61942-5","article-title":"Optimum and stepped care standardised antihypertensive treatment with or without renal denervation for resistant hypertension (DENERHTN): a multicentre, open-label, randomised controlled trial","volume":"385","author":"Azizi","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.tcm.2016.05.004_bib40","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1161\/HYPERTENSIONAHA.114.05010","article-title":"First report of the Global SYMPLICITY Registry on the effect of renal artery denervation in patients with uncontrolled hypertension","volume":"65","author":"Bohm","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/j.tcm.2016.05.004_bib41","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/HYPERTENSIONAHA.114.02925","article-title":"Arteriovenous anastomosis: is this the way to control hypertension?","volume":"64","author":"Burchell","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.tcm.2016.05.004_bib42","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1161\/HYPERTENSIONAHA.115.05325","article-title":"Effect of bilateral carotid body resection on cardiac baroreflex control of blood pressure during hypoglycemia","volume":"65","author":"Limberg","year":"2015","journal-title":"Hypertension"}],"container-title":["Trends in Cardiovascular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173816300482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1050173816300482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T20:50:59Z","timestamp":1536699059000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1050173816300482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":42,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S1050173816300482"],"URL":"https:\/\/doi.org\/10.1016\/j.tcm.2016.05.004","relation":{},"ISSN":["1050-1738"],"issn-type":[{"value":"1050-1738","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Emerging concepts for patients with treatment-resistant hypertension","name":"articletitle","label":"Article Title"},{"value":"Trends in Cardiovascular Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tcm.2016.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}